These shock-induced modulations of phasic response patterns were suppressed by systemic administration of antalarmin (Fig. 5c), a CRHR1 antagonist that reduces anxiety in EPM [48], blocks stress-induced anxiety [49] and abolished the switch to passive behavior in our assay (Supplementary Fig. S13). Here, CRHR1 is linked to Anxiety.